参考文献/References:
[1] MESSMER E M.The pathophysiology,diagnosis,and treatment of dry eye disease[J].Dtsch Arztebl Int,2015,112(5):71-81;quiz82.
[2] TSUBOTA K,PFLUGFELDER S C,LIU Z,BAUDOUIN C,KIM H M,MESSMER E M,et al.Defining dry eye from a clinical perspective[J].Int J Mol Sci,2020,21(23):9271.
[3] DE PAIVA C S,PFLUGFELDER S C,NG S M,AKPEK E K.Topical cyclosporine A therapy for dry eye syndrome[J].Cochrane Database Syst Rev,2019,9(9):CD010051.
[4] SIVAKUMAR G K,PATEL J,MALVANKAR-MEHTA M S,MATHER R.Work productivity among Sjgren’s Syndrome and non-Sjgren’s dry eye patients:a systematic review and meta-analysis[J].Eye,2021,35(12):3243-3257.
[5] TSUBOTA K,YOKOI N,WATANABE H,DOGRU M,KOJIMA T,YAMADA M,et al.A new perspective on dry eye classification:proposal by the Asia dry eye society[J].Eye Contact Lens,2020,46 Suppl(1):S2-S13.
[6] ABDULMANNAN D M,NASER A Y,IBRAHIM O K,MAHMOOD A S,ALYOUSSEF ALKRAD J,SWEISS K,et al.Visual health and prevalence of dry eye syndrome among university students in Iraq and Jordan[J].BMC Ophthalmol,2022,22(1):265.
[7] HUANG R,SU C,FANG L,LU J,CHEN J,DING Y.Dry eye syndrome:comprehensive etiologies and recent clinical trials[J].Int Ophthalmol,2022,42(10):3253-3272.
[8] MCMONNIES C W.Why the symptoms and objective signs of dry eye disease may not correlate[J].J Optom,2021,14(1):3-10.
[9] LEE O L,TEPELUS T C,HUANG J,IRVINE A G,IRVINE C,CHIU G B,et al.Evaluation of the corneal epithelium in non-Sjgren’s and Sjgren’s dry eyes:an in vivo confocal microscopy study using HRT III RCM[J].BMC Ophthalmol,2018,18(1):309.
[10] LI G,LEE C,AGRAHARI V,WANG K,NAVARRO I,SHERWOOD J M,et al.In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model[J].Proc Natl Acad Sci U S A,2019,116(5):1714-1722.
[11] ADELMAN R A,BRAUNER S C,AFSHARI N A,GROSSKREUTZ C L.Cataract formation after initial trabeculectomy in young patients[J].Ophthalmology,2003,110(3):625-629.
[12] HO L J,JUAN T Y,CHAO P,WU W L,CHANG D M,CHANG S Y,et al.Plant alkaloid tetrandrine downregulates IκBα kinases-IκBα-NF-κB signaling pathway in human peripheral blood T cell[J].Br J Pharmacol,2004,143(7):919-927.
[13] ZHAO H,KONG L,SHEN J,MA Y,WU Z,LI H,et al.Tetrandrine inhibits the occurrence and development of frozen shoulder by inhibiting inflammation,angiogenesis,and fibrosis[J].Biomedecine Pharmacother,2021,140:111700.
[14] DU Z,ZHAO W,HUANG Z,CHANG C K,LIU W,LIU X.Inhibition effect of tetrandrine on haze formation after epi-LASIK surgery in rabbits[J].Curr Eye Res,2011,36(8):699-705.
[15] MAGPANTAY H D,MALALUAN I N,MANZANO J A H,QUIMQUE M T,PUEBLOS K R,MOOR N,et al.Antibacterial and COX-2 inhibitory tetrahydrobisbenzylisoquinoline alkaloids from the philippine medicinal plant Phaeanthus ophthalmicus[J].Plants,2021,10(3):462.
[16] XIAO J G,CHIOU G C.Tetrandrine inhibits breakdown of blood-aqueous barrier induced by endotoxin and interleukin-1 alpha in rats[J].J Ocul Pharmacol Ther,1996,12(3):323-329.
[17] HUANG L,GAO H,WANG Z,ZHONG Y,HAO L,DU Z.Combination nanotherapeutics for dry eye disease treatment in a rabbit model[J].Int J Nanomed,2021,16:3613-3631.
[18] HUANG P,XU Y,WEI R,LI H,TANG Y,LIU J,et al.Efficacy of tetrandrine on lowering intraocular pressure in animal model with ocular hypertension[J].J Glaucoma,2011,20(3):183-188.
[19] GALOR A,MOEIN H R,LEE C,RODRIGUEZ A,FELIX E R,SARANTOPOULOS K D,et al.Neuropathic pain and dry eye[J].Ocul Surf,2018,16(1):31-44.
[20] BIKBOV M M,GILMANSHIN T R,ZAINULLIN R M,KAZAKBAEVA G M,IAKUPOVA E M,FAKHRETDINOVA A A,et al.Prevalence and associations of dry eye disease and meibomian gland dysfunction in the Ural eye and medical study[J].Sci Rep,2022,12(1):18849.
[21] AZCARATE P M,VENINCASA V D,FEUER W,STANCZYK F,SCHALLY A V,GALOR A.Androgen deficiency and dry eye syndrome in the aging male[J].Invest Ophthalmol Vis Sci,2014,55(8):5046-5053.
[22] SALDANHA I J,PETRIS R,HAN G,DICKERSIN K,AKPEK E K.Research questions and outcomes prioritized by patients with dry eye[J].JAMA Ophthalmol,2018,136(10):1170-1179.